
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
08/21/2025 | Q3 | $490.8M | -- | -- | $0.55 | -- |
06/17/2025 | Q2 | $557.4M | $570.9M | $0.36 | $0.93 | -$0.57 |
02/18/2025 | Q1 | $516.5M | $521.8M | $0.68 | $0.67 | $0.01 |
11/19/2024 | Q4 | $506M | $521M | $0.71 | $0.64 | $0.07 |
08/20/2024 | Q3 | $482.2M | $495.5M | $0.61 | $0.60 | $0.01 |
06/17/2024 | Q2 | $516.4M | $553.5M | $0.91 | $0.70 | $0.21 |
02/20/2024 | Q1 | $523.1M | $500.4M | $0.66 | $0.72 | -$0.06 |
11/29/2023 | Q4 | $502.3M | $511.4M | $0.63 | $0.62 | $0.01 |
08/22/2023 | Q3 | $474.6M | $481.7M | $0.63 | $0.55 | $0.08 |
06/20/2023 | Q2 | $533M | $561.3M | $0.78 | $0.72 | $0.06 |
02/21/2023 | Q1 | -- | $572.7M | $0.74 | -- | -- |
11/30/2022 | Q4 | -- | $611.3M | $1.07 | -- | -- |
08/24/2022 | Q3 | -- | $604.1M | $0.89 | -- | -- |
06/21/2022 | Q2 | -- | $684.6M | $1.32 | -- | -- |
02/15/2022 | Q1 | -- | $571.6M | $0.65 | -- | -- |
11/16/2021 | Q4 | -- | $575.9M | $0.89 | -- | -- |
08/17/2021 | Q3 | -- | $524.8M | $0.54 | -- | -- |
06/15/2021 | Q2 | -- | $519.5M | $0.81 | -- | -- |
02/16/2021 | Q1 | -- | $470.2M | $0.62 | -- | -- |
11/17/2020 | Q4 | -- | $459.1M | $0.75 | -- | -- |
08/18/2020 | Q3 | -- | $285.5M | $0.10 | -- | -- |
06/23/2020 | Q2 | -- | $367.3M | $0.05 | -- | -- |
02/18/2020 | Q1 | -- | $475.9M | $0.74 | -- | -- |
11/20/2019 | Q4 | -- | $447.2M | $0.48 | -- | -- |
08/20/2019 | Q3 | -- | $413.6M | $0.38 | -- | -- |
06/18/2019 | Q2 | -- | $453.8M | $0.03 | -- | -- |
02/19/2019 | Q1 | -- | $467.6M | $0.61 | -- | -- |
11/28/2018 | Q4 | -- | $439.3M | $0.42 | -- | -- |
08/22/2018 | Q3 | -- | $384.7M | $0.39 | -- | -- |
06/20/2018 | Q2 | -- | $420M | $0.72 | -- | -- |
02/20/2018 | Q1 | -- | $413.6M | $0.25 | -- | -- |
11/29/2017 | Q4 | -- | $393.2M | $0.47 | -- | -- |
08/22/2017 | Q3 | -- | $357.1M | $0.24 | -- | -- |
06/21/2017 | Q2 | -- | $412.7M | $0.57 | -- | -- |
02/22/2017 | Q1 | -- | $390M | $0.47 | -- | -- |
12/01/2016 | Q4 | -- | $376.6M | $0.42 | -- | -- |
08/24/2016 | Q3 | -- | $340.8M | $0.28 | -- | -- |
06/22/2016 | Q2 | -- | $417.1M | $0.44 | -- | -- |
02/18/2016 | Q1 | -- | $384M | $0.43 | -- | -- |
11/18/2015 | Q4 | -- | $382.9M | $0.41 | -- | -- |
08/19/2015 | Q3 | -- | $341.4M | $0.27 | -- | -- |
La-Z-Boy reported $570.9M worth of top line sales in its most recent quarter.
La-Z-Boy announced earnings per share of $0.36 which represents a miss of analyst forecast a $0.93 per share.
La-Z-Boy reported $251.1M that represents $5.94 per share over the last quarter.
La-Z-Boy's earnings are forecast to grow from $2.35 per share to $2.95 per share next year representing an increase of 36.6%.
La-Z-Boy's next earnings date is August 21, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.